advertisement

HaagStreit

Iwamura R 14

Showing records 1 to 14 | Display all abstracts from Iwamura R

78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fuwa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Toris CB
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Tanaka M
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fan S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Okanari E; Kirihara T
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Taniguchi T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Odani-Kawabata N
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Ichikawa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Shams N
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Odani-Kawabata N; Iwamura R; Iwamura R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Yoneda K
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Yoneda K; Matsugi T; Shams NK; Zhang JZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537

Issue 19-4

Select Issue


advertisement

HaagStreit